INSYS Therapeutics Inc (NASDAQ:INSY)

8.15
Delayed Data
As of Jun 22
 -0.26 / -3.09%
Today’s Change
4.10
Today|||52-Week Range
14.00
-15.28%
Year-to-Date

Today’s Trading

Previous close8.41
Today’s open8.45
Day’s range8.03 - 8.48
Volume1,133,006
Average volume (3 months)659,096
Market cap$543.2M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-3,260.00%
Earnings growth (this year)+17.76%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)-41.93%
P/E ratioNM
Price/Sales4.94
Price/Book8.56

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.19+1.03%
ACHNAchillion Pharmaceut...+0.01+0.35%
PRTKParatek Pharmaceutic...-0.15-1.39%
HSKAHeska Corp-0.07-0.07%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$140.7M
Annual profit (last year)-$228.0M
Net profit margin-162.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Saeed Motahari
CFO &
Principal Accounting Officer
Andrew G. Long
Corporate headquarters
Chandler, Arizona

Forecasts